Aurobindo Pharma shares rise 3.26% in early trade

Shares of Aurobindo Pharma gained 3.26% to trade at Rs 1,084.50 on Thursday. At 9:16 am, Aurobindo Pharma showed positive movement in today's session. Aurobindo Pharma is included as one of the stocks in the Nifty Midcap 150 index.

Financial Snapshot

Here is a look at the company's recent financial performance:

Consolidated Quarterly Results

Aurobindo Pharma's quarterly revenue and net profit figures are as follows (in Rs Crore):
The company's revenue increased steadily from June 2024 to March 2025, followed by a slight decrease in June 2025. Net profit also experienced fluctuations, with the highest profit recorded in March 2025.

Consolidated Yearly Results

Aurobindo Pharma's yearly revenue, net profit, and EPS figures are as follows (in Rs Crore):
The annual revenue for Aurobindo Pharma has shown a consistent increase from 2021 to 2025. The net profit saw a decrease between 2021 and 2023, but has since recovered and increased. The debt to equity ratio has remained relatively stable over the years.

Income Statement Yearly

Income Statement Quarterly

Cash Flow

Balance Sheet

Key Ratios

Corporate Actions

Aurobindo Pharma has undertaken several corporate actions, including shareholder meetings and dividend announcements. The company's 38th Annual General Meeting (AGM) was held on September 10, 2025. An interim dividend of Rs 4 per share (400%) was announced on August 4, 2025, with an effective date of August 8, 2025.

The company also completed a US FDA inspection at Unit-XII of Aurobindo Pharma Limited, as announced on September 5, 2025.

Additionally, the company has a history of bonus issues, including a 1:1 bonus ratio on July 20, 2015.

The stock is currently trading higher following the recent corporate developments.

A Moneycontrol analysis on September 10, 2025, indicated bearish sentiment on the stock.